Literature DB >> 25663760

Jaundice associated pruritis: a review of pathophysiology and treatment.

Ramez Bassari1, Jonathan B Koea1.   

Abstract

To review the underlying pathophysiology and currently available treatments for pruritis associated with jaundice. English language literature was reviewed using MEDLINE, PubMed, EMBASE and clinicaltrials.gov for papers and trails addressing the pathophysiology and potential treatments for pruritis associated with jaundice. Recent advances in the understanding of the peripheral anatomy of itch transmission have defined a histamine stimulated pathway and a cowhage stimulated pathway with sensation conveyed centrally via the contralateral spinothalamic tract. Centrally, cowhage and histamine stimulated neurons terminate widely within the thalamus and sensorimotor cortex. The causative factors for itch in jaundice have not been clarified although endogenous opioids, serotonin, steroid and lysophosphatidic acid all play a role. Current guidelines for the treatment of itching in jaundice recommend initial management with biliary drainage where possible and medical management with ursodeoxycholic acid, followed by cholestyramine, rifampicin, naltrexone and sertraline. Other than biliary drainage no single treatment has proved universally effective. Pruritis associated with jaundice is a common but poorly understood condition for which biliary drainage is the most effective therapy. Pharmacological therapy has advanced but remains variably effective.

Entities:  

Keywords:  Bile acids; Biliary drainage; Jaundice; Lysophosphatidic acid; Pruritis

Mesh:

Substances:

Year:  2015        PMID: 25663760      PMCID: PMC4316083          DOI: 10.3748/wjg.v21.i5.1404

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  100 in total

Review 1.  Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis.

Authors:  E A Jones; N V Bergasa
Journal:  Can J Gastroenterol       Date:  2000-01       Impact factor: 3.522

2.  MARS: The ultimate warrior against pruritus of cholestasis?

Authors:  O Chazouillères
Journal:  J Hepatol       Date:  2010-05-06       Impact factor: 25.083

Review 3.  The multiple pathways for itch and their interactions with pain.

Authors:  Steve Davidson; Glenn J Giesler
Journal:  Trends Neurosci       Date:  2010-11-05       Impact factor: 13.837

4.  Lysophosphatidic acid is a potential mediator of cholestatic pruritus.

Authors:  Andreas E Kremer; Job J W W Martens; Wim Kulik; Franziska Ruëff; Edith M M Kuiper; Henk R van Buuren; Karel J van Erpecum; Jurate Kondrackiene; Jesus Prieto; Christian Rust; Victoria L Geenes; Catherine Williamson; Wouter H Moolenaar; Ulrich Beuers; Ronald P J Oude Elferink
Journal:  Gastroenterology       Date:  2010-06-19       Impact factor: 22.682

Review 5.  Pathophysiology and current management of pruritus in liver disease.

Authors:  Andreas E Kremer; Ronald P J Oude Elferink; Ulrich Beuers
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-02       Impact factor: 2.947

6.  Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers.

Authors:  Albert Parés; Manuel Herrera; Juan Avilés; Miquel Sanz; Antoni Mas
Journal:  J Hepatol       Date:  2010-05-07       Impact factor: 25.083

Review 7.  Pruritus: an overview of current concepts.

Authors:  Martin Metz; Sonja Grundmann; Sonja Ständer
Journal:  Vet Dermatol       Date:  2011-01-20       Impact factor: 1.589

Review 8.  Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.

Authors:  Ngoc Quan Phan; Jeffrey D Bernhard; Thomas A Luger; Sonja Ständer
Journal:  J Am Acad Dermatol       Date:  2010-05-11       Impact factor: 11.527

9.  The molecular mechanism of cholestatic pruritus.

Authors:  Ronald P J Oude Elferink; Andreas E Kremer; Job J W W Martens; Ulrich H Beuers
Journal:  Dig Dis       Date:  2011-06-17       Impact factor: 2.404

Review 10.  Medical palliation of the jaundiced patient with pruritus.

Authors:  Nora V Bergasa
Journal:  Gastroenterol Clin North Am       Date:  2006-03       Impact factor: 3.806

View more
  8 in total

Review 1.  Treatment of Malignant Bile Duct Obstruction: What the Interventional Radiologist Needs to Know.

Authors:  Juan C Camacho; Lynn A Brody; Anne M Covey
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

2.  Targets and Effective Constituents of ZhiziBaipi Decoction for Treating Damp-Heat Jaundice Syndrome Based on Chinmedomics Coupled with UPLC-MS/MS.

Authors:  Wen-Feng Wei; Hui Sun; Shao-Bo Liu; Sheng-Wen Lu; Ai-Hua Zhang; Wan-Ying Wang; Wen-Jun Chai; Fang-Fang Wu; Guang-Li Yan; Yu Guan; Xi-Jun Wang
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

Review 3.  Bilirubin as a metabolic hormone: the physiological relevance of low levels.

Authors:  Justin F Creeden; Darren M Gordon; David E Stec; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

4.  Identification of a bilirubin receptor that may mediate a component of cholestatic itch.

Authors:  James Meixiong; Chirag Vasavda; Dustin Green; Qin Zheng; Lijun Qi; Shawn G Kwatra; James P Hamilton; Solomon H Snyder; Xinzhong Dong
Journal:  Elife       Date:  2019-01-21       Impact factor: 8.140

5.  Evaluation of Associated Markers of Neonatal Pathological Jaundice Due to Bacterial Infection.

Authors:  Yanli Liu; Xiuhua Sun; Yaqiong Wang; Cuihong Xing; Li Li; Shiying Zhou
Journal:  Iran J Public Health       Date:  2021-02       Impact factor: 1.429

6.  Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study.

Authors:  Bingjing Zhou; Cong Peng; Liqiao Li; Runqiu Liu; Lei Zhu; Xiang Chen; Jie Li
Journal:  Front Med (Lausanne)       Date:  2022-03-23

7.  Yellow urticaria and biliary pancreatitis.

Authors:  Eira Mabel Nava Cruz; Juan Pablo Castanedo-Cázares; Diana Vianney Hernández Blanco; Bertha Torres-Álvarez
Journal:  JAAD Case Rep       Date:  2017-09-08

Review 8.  TRP Channels as Drug Targets to Relieve Itch.

Authors:  Zili Xie; Hongzhen Hu
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.